Good Life Advisors LLC Sells 617 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Good Life Advisors LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 39.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 928 shares of the healthcare conglomerate’s stock after selling 617 shares during the quarter. Good Life Advisors LLC’s holdings in UnitedHealth Group were worth $470,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently made changes to their positions in UNH. Jmac Enterprises LLC boosted its holdings in UnitedHealth Group by 2.2% in the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares during the period. Wallace Capital Management Inc. grew its position in UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after buying an additional 19 shares in the last quarter. Western Pacific Wealth Management LP raised its holdings in shares of UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after acquiring an additional 19 shares in the last quarter. JNBA Financial Advisors grew its holdings in shares of UnitedHealth Group by 0.4% during the third quarter. JNBA Financial Advisors now owns 4,686 shares of the healthcare conglomerate’s stock worth $2,740,000 after purchasing an additional 20 shares in the last quarter. Finally, Paragon Capital Management LLC raised its stake in UnitedHealth Group by 2.9% in the third quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate’s stock valued at $422,000 after purchasing an additional 20 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on UNH. KeyCorp reissued an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Barclays cut their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Price Performance

UNH opened at $503.01 on Friday. The stock’s 50 day moving average price is $520.37 and its 200-day moving average price is $561.26. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market capitalization of $462.91 billion, a PE ratio of 32.45, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 EPS. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.